Cargando…

Drug-refractory Heart Failure in Female Carrier of Duchenne Muscular Dystrophy: A Case of X-linked Dilated Cardiomyopathy

A 56-year-old woman was referred to our hospital for the further evaluation of drug-refractory heart failure with a reduced ejection fraction. A family history interview revealed that men in her family had died of Duchenne muscular dystrophy (DMD), whereas she had no skeletal muscle disorder. Myocar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohtani, Hayato, Saotome, Masao, Sakamoto, Atsushi, Suwa, Kenichiro, Maekawa, Yuichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400384/ https://www.ncbi.nlm.nih.gov/pubmed/36450469 http://dx.doi.org/10.2169/internalmedicine.0745-22

Ejemplares similares

Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy
por: Barp, Andrea, et al.
Publicado: (2015)

Brain natriuretic peptide is not predictive of dilated cardiomyopathy in Becker and Duchenne muscular dystrophy patients and carriers
por: Schade van Westrum, Steven, et al.
Publicado: (2013)

Recurrent Coronary Thrombus in a Patient with Chronic Immune Thrombocytopenia with Treatment Using Eltrombopag
por: Satoh, Terumori, et al.
Publicado: (2019)

Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022)

Three Cases of Manifesting Female Carriers in Patients with Duchenne Muscular Dystrophy
por: Song, Tae-Jin, et al.
Publicado: (2011)

Dysregulation of Calcium Handling in Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy: Mechanisms and Experimental Therapeutic Strategies
por: Law, Michelle L., et al.
Publicado: (2020)

Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy
por: Sano, Makoto, et al.
Publicado: (2016)

Serum MyomiRs as Biomarkers for Female Carriers of Duchenne/Becker Muscular Dystrophy
por: Zhang, Jiapeng, et al.
Publicado: (2020)

A manifesting female carrier of Duchenne muscular dystrophy: importance of genetics for the dystrophinopathies
por: Quak, Zhi Xuan, et al.
Publicado: (2023)

Carrier Woman of Duchenne Muscular Dystrophy Mimicking Inflammatory Myositis
por: Yoon, Jiyeol, et al.
Publicado: (2011)

Patterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers
por: Giglio, Vincenzo, et al.
Publicado: (2014)

Carrier detection in Duchenne muscular dystrophy using molecular methods
por: Sakthivel Murugan, S.M., et al.
Publicado: (2013)

Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection
por: Anaya-Segura, Mónica Alejandra, et al.
Publicado: (2015)

Cardiotoxicity of Carfilzomib in Two Japanese Patients with Relapsed Multiple Myeloma
por: Ikoma, Takenori, et al.
Publicado: (2019)

Predictors of Death in Adults With Duchenne Muscular Dystrophy–Associated Cardiomyopathy
por: Cheeran, Daniel, et al.
Publicado: (2017)

Cardiomyopathy in Duchenne Muscular Dystrophy: A Single-Center Experience
por: Kummitha, Karthikeyan, et al.
Publicado: (2022)

Association of an Increased Abnormal Mitochondria Ratio in Cardiomyocytes with a Prolonged Oxygen Uptake Time Constant during Cardiopulmonary Exercise Testing of Patients with Non-ischemic Cardiomyopathy
por: Ikoma, Takenori, et al.
Publicado: (2022)

Combined ablation for paroxysmal atrial fibrillation and drug-refractory hypertrophic obstructive cardiomyopathy: a case report
por: Akita, Keitaro, et al.
Publicado: (2021)

Corrigendum: Serum MyomiRs as Biomarkers for Female Carriers of Duchenne/Becker Muscular Dystrophy
por: Zhang, Jiapeng, et al.
Publicado: (2020)

miRNome profiling in Duchenne muscular dystrophy; identification of asymptomatic and manifesting female carriers
por: Mousa, Nahla O., et al.
Publicado: (2021)

Utility of MLPA in mutation analysis and carrier detection for Duchenne muscular dystrophy
por: Verma, Prashant K., et al.
Publicado: (2012)

Individualised left anterior oblique projection for lead implantation into interventricular septum
por: Narumi, Taro, et al.
Publicado: (2022)

Implications of notch signaling in duchenne muscular dystrophy
por: Den Hartog, Lily, et al.
Publicado: (2022)

Current Understanding of Molecular Pathology and Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy
por: van Westering, Tirsa L. E., et al.
Publicado: (2015)

Vascular therapy for Duchenne muscular dystrophy (DMD)
por: Thapa, Sangharsha, et al.
Publicado: (2023)

Vascular-targeted therapies for Duchenne muscular dystrophy
por: Ennen, James P, et al.
Publicado: (2013)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Experiences of Women Who Have Had Carrier Testing for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy During Adolescence
por: Fraser, Harry G., et al.
Publicado: (2018)

Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy
por: Lin, Bo, et al.
Publicado: (2015)

Serum creatine phosphokinase in the detection of carriers of Duchenne's muscular dystrophy in Northern Ireland.
por: McCormick, D., et al.
Publicado: (1976)

Differences in carrier frequency between mothers of Duchenne and Becker muscular dystrophy patients
por: Lee, Tomoko, et al.
Publicado: (2014)

Population-Wide Duchenne Muscular Dystrophy Carrier Detection by CK and Molecular Testing
por: Han, Shuai, et al.
Publicado: (2020)

Becker muscular dystrophy with dilated cardiomyopathy: A case report
por: Chen, Yongliang, et al.
Publicado: (2021)

Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation
por: Ikoma, Takenori, et al.
Publicado: (2022)

Prevalence and Characteristics of Inspiration-Induced Negative Left Atrial Pressure during Pulmonary Vein Isolation
por: Ikoma, Takenori, et al.
Publicado: (2023)

Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice
por: Voit, Antanina, et al.
Publicado: (2017)

Cardiomyopathy as cause of death in Duchenne muscular dystrophy: a longitudinal observational study
por: Lechner, Annabel, et al.
Publicado: (2023)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

The role of fibrosis in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_10jq0749r4dnrf1rep0bpleelm